Try our beta test site
662 studies found for:    GVHD
Show Display Options
Rank Status Study
1 Terminated Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)
Conditions: Graft-vs-Host Disease;   GVHD
Intervention: Drug: Brentuximab Vedotin
2 Not yet recruiting A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
Conditions: Graft Vs Host Disease;   GVHD
Interventions: Drug: Pacritinib;   Drug: Sirolimus;   Drug: Tacrolimus
3 Completed Alefacept for Chronic Graft Versus Host Disease
Condition: Resistant Chronic GVHD
Intervention: Drug: Alefacept
4 Unknown  Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease
Condition: Ocular GVHD
Interventions: Drug: Tacrolimus;   Drug: Methylprednisolone Sodium Succinate
5 Active, not recruiting Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Condition: Chronic GVHD
Interventions: Drug: Sirolimus + calcineurin inhibitor + prednisone;   Drug: Sirolimus + prednisone
6 Recruiting Pilot Study of Telmisartan (Micardis) For the Prevention of Acute Graft vs. Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation
Condition: GVHD
Intervention: Drug: Telmisartan
7 Active, not recruiting
Has Results
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
Condition: Graft Versus Host Disease
Interventions: Procedure: stem cell transplant;   Drug: tacrolimus (standard GVHD prophylaxis);   Drug: mycophenolate (standard GVHD prophylaxis);   Drug: etanercept;   Drug: methoxsalen
8 Recruiting Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
Conditions: Graft Versus Host Disease;   GVHD
Interventions: Drug: Panobinostat;   Drug: Sirolimus;   Drug: Tacrolimus
9 Recruiting Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients
Conditions: Dry Eye;   GVHD
Intervention: Other: Cross-sectional study
10 Recruiting Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis
Condition: Graft Versus Host Disease (GVHD)
Interventions: Procedure: extracorporeal photopheresis;   Other: laboratory biomarker analysis
11 Completed Efficacy and Safety of Prochymal™ Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute GVHD
Condition: Graft Versus Host Disease
Interventions: Drug: Prochymal;   Other: Placebo
12 Completed Feasibility Study of Collecting Multicenter Chronic GVHD Data
Condition: Graft-Versus-Host Disease
Intervention: Behavioral: Questionnaire
13 Unknown  Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease
Condition: Steroid-Refractory Chronic GVHD
Intervention: Drug: Rituximab
14 Completed Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Patients
Condition: Graft Versus Host Disease
Intervention: Drug: Prochymal (TM)
15 No longer available Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD
Conditions: Graft vs Host Disease;   Graft-Versus-Host Disease
Intervention: Biological: remestemcel-L
16 Recruiting Maraviroc as GVHD Prophylaxis in Transplant Recipients
Conditions: Diagnoses That Require Stem Cell Transplant;   Graft Versus Host Disease (GVHD)
Intervention: Drug: Maraviroc
17 No longer available Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute GVHD
Condition: Graft-Versus-Host Disease
Intervention: Drug: Prochymal®
18 Recruiting Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD
Condition: Chronic GVHD After HCT for Cancer or Immune Disease
Intervention: Other: Autologous peripheral blood mononuclear cells ex vivo depleted for reactive T cells, using TH9402 based photodynamic therapy, in a final formulation of 10% DMSO, 30% autologous plasma in PlasmaLyte.
19 Completed Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD
Condition: Graft Versus Host Disease
Intervention: Device: D-SQUAME Skin Sampling Discs
20 Active, not recruiting Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD
Condition: Chronic Graft Versus Host Disease
Intervention: Drug: Ponesimod

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.